FDA NDC Directory · JSON-LD · Markdown

Quinine Sulfate

NDC 0093-3002 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA091661
Dosage form / routeCAPSULE · ORAL
Active ingredientsQUININE SULFATE (324 mg/1)
Marketing started20120928
Package count1

External sources

Source: openFDA. Public-domain (CC0).